Publications by authors named "Adelaide Hebert"

Claim this Profile
C
Characteristics and management of follicular events and contact dermatitis in patients using tapinarof cream for the treatment of atopic dermatitis or plaque psoriasis.
Linda Stein Gold, Matthew J Bruno, G Michael Lewitt, Adelaide A Hebert

J Dermatolog Treat· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials.
Kim A Papp, James Q Del Rosso, Mark G Lebwohl, Melinda J Gooderham, Adelaide A Hebert

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents.
Robert Bissonnette, Jennifer Soung, Adelaide A Hebert, Andrew E Pink, Andreas Pinter

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond Inflammation and Itch: A Call for a Broader Framework in Atopic Dermatitis.
Peter Lio, Adelaide A Hebert, Lawrence A Schachner

J Drugs Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin clearance, duration of treatment-free interval, and safety of tapinarof cream 1% once daily: Results from ADORING 3, a 48-week phase 3 open-label extension trial in adults and children down to 2 years of age with atopic dermatitis.
Robert Bissonnette, Linda Stein Gold, Leon Kircik, Eric L Simpson, Lawrence F Eichenfield, Adelaide A Hebert

J Am Acad Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Atopic Dermatitis Continuum: An Updated Paradigm for a Common Disorder and a Novel Multipurpose Treatment Option.
Lawrence A Schachner, Adelaide A Hebert, Nanette Silverberg, Anneke Andriessen, Pearl C Kwong

J Drugs Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Tolerability of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Truncal Acne.
Leon H Kircik, Julie C Harper, Michael Gold, Linda Stein Gold, Zoe D Draelos, Adelaide A Hebert

J Drugs Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Evidence of Safety, Clinical Benefit, and Pharmacokinetics of Roflumilast Cream 0.3% Once Daily for Treatment of Mild or Moderate Plaque Psoriasis in Children Aged 2-11 Years.
Adelaide A Hebert, Shireen V Guide, Vlada Groysman, Mercedes E Gonzalez, Daisy Blanco

Pediatr Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sofpironium topical gel, 12.45%, for the treatment of axillary hyperhidrosis: Pooled efficacy and safety results from 2 phase 3 randomized, controlled, double-blind studies.
David Pariser, Dee Anna Glaser, James Del Rosso, Neal Bhatia, Deirdre Hooper, Adelaide Hebert

J Am Acad Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from Adalimumab Reference Product to and Among Adalimumab Biosimilars Outside the USA: Insights for US Clinicians.
John R P Tesser, Aline Charabaty, Adelaide A Hebert

BioDrugs· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Onset of Itch Relief With Tapinarof in Two Phase 3 Trials in Atopic Dermatitis.
Eric L Simpson, Jonathan I Silverberg, Robert Bissonnette, Linda Stein Gold, April Armstrong, Adelaide A Hebert

J Drugs Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Algorithm on Topical Treatment of Flaring Atopic Dermatitis (AD) With or Without Secondary Infection.
Lawrence A Schachner, Adelaide A Hebert, Robert Sidbury, Anneke Andriessen, Vanja Adzovic

J Drugs Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INDIVIDUAL ARTICLE: Real-World Clinical Case Series Utilizing Acneceuticals as Monotherapy, Adjunctive, or Maintenance Therapy for Acne Vulgaris.
Hilary Baldwin, Cheri Frey, Adelaide Hebert, Edward Ted Lain, Evan Rieder

J Drugs Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis.
Amy S Paller, Adelaide A Hebert, Mercedes E Gonzalez, Victoria Butners, Nancy Fitzgerald

Am J Clin Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Algorithm Integrating Acneceuticals into the Management of Acne Vulgaris.
Hilary Baldwin, Cheri Frey, Adelaide Hebert, Edward Ted Lain, Todd Schlesinger

J Drugs Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial.
Lawrence F Eichenfield, Rocco Serrao, Vimal H Prajapati, John C Browning, Lisa Swanson, Adelaide A Hebert

Pediatr Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations to Improve Outcomes in Acne and Acne Sequelae: A Focus on Trifarotene and Other Retinoids.
Naiem Issa, Andrew Alexis, Hilary Baldwin, Iltefat Hamzavi, Adelaide Hebert

Dermatol Ther (Heidelb)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Acneceuticals to Improve Acne Care: Introduction of a New Term and Review of the Literature.
Hilary Baldwin, Helen Bui, Valerie Callender, Cheri Frey, Adelaide Hebert

J Drugs Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibodies for the management of cutaneous lupus erythematosus: an update on the current treatment landscape.
Alexander J Jafari, Christina McGee, Natasha Klimas, Adelaide A Hebert

Clin Exp Dermatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children.
Eric L Simpson, Adelaide A Hebert, John Browning, Rocco T Serrao, Howard Sofen

Dermatol Ther (Heidelb)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial.
Eric L Simpson, Lawrence F Eichenfield, Kim A Papp, Seth B Forman, Adelaide A Hebert

Dermatitis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne in Children and Adolescents.
Lawrence F Eichenfield, Adelaide A Hebert, Julie C Harper, Hilary Baldwin, Neal Bhatia

J Drugs Dermatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Response to Sirolimus in Patients with PIK3CA-Related Overgrowth Spectrum.
Jessica R Nye, Jackson C Green, Michael Talanker, Jose Barrera, Kate Richardson, Adelaide A Hebert

Eplasty· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials.
Eric L Simpson, Lawrence F Eichenfield, Javier Alonso-Llamazares, Zoe D Draelos, Laura K Ferris, Adelaide A Hebert

JAMA Dermatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Consensus on Staphylococcus aureus Exacerbated Atopic Dermatitis and the Need for a Novel Treatment.
Lawrence A Schachner, Anneke Andriessen, Mercedes E Gonzalez, Karan Lal, Adelaide A Hebert

J Drugs Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis